These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 23165334)

  • 21. Lumican expression in pancreatic ductal adenocarcinoma.
    Yang ZX; Lu CY; Yang YL; Dou KF; Tao KS
    Hepatogastroenterology; 2013; 60(122):349-53. PubMed ID: 22951524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of uridine diphosphate N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalactosaminyl transferase 3 in adenocarcinoma of the pancreas.
    Yamamoto S; Nakamori S; Tsujie M; Takahashi Y; Nagano H; Dono K; Umeshita K; Sakon M; Tomita Y; Hoshida Y; Aozasa K; Kohno K; Monden M
    Pathobiology; 2004; 71(1):12-8. PubMed ID: 14555840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative evaluation of cancer stem cell markers in normal pancreas and pancreatic ductal adenocarcinoma.
    Vizio B; Mauri FA; Prati A; Trivedi P; Giacobino A; Novarino A; Satolli MA; Ciuffreda L; Camandona M; Gasparri G; Bellone G
    Oncol Rep; 2012 Jan; 27(1):69-76. PubMed ID: 21922151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
    Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
    Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.
    Koopmann J; Fedarko NS; Jain A; Maitra A; Iacobuzio-Donahue C; Rahman A; Hruban RH; Yeo CJ; Goggins M
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):487-91. PubMed ID: 15006928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN).
    Karamitopoulou E; Zlobec I; Tornillo L; Carafa V; Schaffner T; Brunner T; Borner M; Diamantis I; Zimmermann A; Terracciano L
    Pathology; 2010 Apr; 42(3):229-34. PubMed ID: 20350215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does neoplastic cholecystokinin expression reflect the embryonal pattern of the protein? A study in human pancreas.
    Tamiolakis D; Venizelos I; Simopoulos C; Lambropoulou M; Kotini A; Jivannakis T; Alexiadis G; Boglou P; Papadopoulos N
    Acta Medica (Hradec Kralove); 2004; 47(2):101-5. PubMed ID: 15446358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis.
    Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M
    J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histologic characteristics of pancreatic intraepithelial neoplasia associated with different pancreatic lesions.
    Recavarren C; Labow DM; Liang J; Zhang L; Wong M; Zhu H; Wang J; Francis F; Xu R
    Hum Pathol; 2011 Jan; 42(1):18-24. PubMed ID: 21056895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopontin but not parathyroid hormone-related protein predicts prognosis in human renal cell carcinoma.
    Papworth K; Bergh A; Grankvist K; Ljungberg B; Sandlund J; Rasmuson T
    Acta Oncol; 2013 Jan; 52(1):159-65. PubMed ID: 22731830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of topoisomerase IIa expression in pancreatic ductal adenocarcinoma: a pilot study using chromogenic in situ hybridization and immunohistochemistry on tissue microarrays.
    Tsiambas E; Karameris A; Tiniakos DG; Karakitsos P
    Pancreatology; 2007; 7(1):45-52. PubMed ID: 17449965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic evaluation and staging of pancreatic ductal adenocarcinoma.
    McIntyre CA; Winter JM
    Semin Oncol; 2015 Feb; 42(1):19-27. PubMed ID: 25726049
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.
    Tamiolakis D; Simopoulos C; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Koutsougeras G; Alexiadis G; Menegaki M; Papadopoulos N
    Clin Exp Med; 2005 Oct; 5(3):106-11. PubMed ID: 16284732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
    Sullivan J; Blair L; Alnajar A; Aziz T; Ng CY; Chipitsyna G; Gong Q; Witkiewicz A; Weber GF; Denhardt DT; Yeo CJ; Arafat HA
    Surgery; 2009 Aug; 146(2):232-40. PubMed ID: 19628079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pancreatic-polypeptide in the human pancreas: expression and quantitative variation during development and in ductal adenocarcinoma.
    Tamiolakis D; Simopoulos C; Kotini A; Venizelos I; Jivannakis T; Papadopoulos N
    Acta Medica (Hradec Kralove); 2003; 46(1):9-14. PubMed ID: 12747533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synchronous gastric adenocarcinoma and pancreatic ductal adenocarcinoma.
    Muroni M; D'Angelo F; Pezzatini M; Sebastiani S; Noto S; Pilozzi E; Ramacciato G
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):97-9. PubMed ID: 20133238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.
    Lazar M; Sullivan J; Chipitsyna G; Aziz T; Salem AF; Gong Q; Witkiewicz A; Denhardt DT; Yeo CJ; Arafat HA
    Surgery; 2010 Aug; 148(2):298-309. PubMed ID: 20579680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Morphometric microvascular characteristics in the prognosis of pancreatic and ampullary carcinoma.
    Giannopoulos G; Kavantzas N; Parasi A; Tiniakos D; Peros G; Tzanakis N; Patsouris E; Pavlakis K
    Pancreas; 2007 Jul; 35(1):47-52. PubMed ID: 17575545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.